Please assess the completion status of the following clinical trial:

Trial Title: E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
lnclusion Criteria:~* Male and female patients 20 to less than 80 years of age at the time of informed consent~* Patients histologically or cytologically diagnosed to have peripheral T -cell lymphoma~* Patients with a history of chemotherapy (including PUVA and retinoid) that resulted in relapse, recurrence and treatment resistance (just for the administration of E7777 alone)~* Patients subject to CHOP therapy and without a history of prior treatment with anthracycline or anthraquinone anticancer drugs (just for the administration of E7777 in combination with CHOP therapy)~* Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1~* No carry-over of beneficial or adverse effects of the prior treatment that may affect the safety evaluation of the investigational drug (excluding Grade 1 neuropathy and alopecia)~Exclusion Criteria:~* Brain metastasis with clinical symptoms which requires treatment~* Serious systemic infection requiring intensive treatment~* Serious complications or histories~* History of hypersensitivity to protein therapeutics~* Known to be positive for HIV antibody, HCV antibody, or HBs antigen~* History of malignancy other than peripheral T-cell lymphoma and less than five years have elapsed since the last remission~* Patients who have undergone allogeneic hematopoietic stem cell transplantation~* Patients with a relapse within 6 months after autologous hematopoietic stem-cell transplantation

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- E7777 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).